Analystreport

La Jolla Pharmaceutical Company (NASDAQ: LJPC) is now covered by analysts at J P Morgan Chase & Co. They set an "overweight" rating on the stock.

La Jolla Pharmaceutical Company  (LJPC) 
Last la jolla pharmaceutical company earnings: 3/2 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: lajollapharmaceutical.com/investor-relations